340 related articles for article (PubMed ID: 16190395)
1. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
2. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
[TBL] [Abstract][Full Text] [Related]
3. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
6. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
7. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007
[TBL] [Abstract][Full Text] [Related]
8. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
9. [Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease].
Lin SD; Dai AG; Xu P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):97-101. PubMed ID: 15854390
[TBL] [Abstract][Full Text] [Related]
10. [Clinical observation and expression of C-reactive protein by LPS-induced A549 cells in patients with chronic obstructive pulmonary disease].
Wu SJ; Zhao SP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):207-10. PubMed ID: 15898436
[TBL] [Abstract][Full Text] [Related]
11. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
12. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
13. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
14. [Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
Tian L; Cai L; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):138-40. PubMed ID: 11778483
[TBL] [Abstract][Full Text] [Related]
15. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
17. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
18. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
19. Association of oxidative stress markers and C-reactive protein with multidimensional indexes in COPD.
Folchini F; Nonato NL; Feofiloff E; D'Almeida V; Nascimento O; Jardim JR
Chron Respir Dis; 2011; 8(2):101-8. PubMed ID: 21436222
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels in the serum of asthmatic patients.
Fujita M; Ueki S; Ito W; Chiba T; Takeda M; Saito N; Kayaba H; Chihara J
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):48-53. PubMed ID: 17650829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
